Your browser doesn't support javascript.
loading
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.
Yamada, Miko; Miller, Dennis M; Lowe, Melinda; Rowe, Casey; Wood, Dominic; Soyer, H Peter; Byrnes-Blake, Kelly; Parrish-Novak, Julia; Ishak, Laura; Olson, James M; Brandt, Gordon; Griffin, Paul; Spelman, Lynda; Prow, Tarl W.
Afiliación
  • Yamada M; The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
  • Miller DM; Blaze Bioscience, Inc., Seattle, WA, USA.
  • Lowe M; Blaze Bioscience Australia Pty Ltd, Caulfield North, Victoria, Australia.
  • Rowe C; Medicines Development Limited, Southbank, Victoria, Australia.
  • Wood D; Veracity Clinical Research, Brisbane, Queensland, Australia.
  • Soyer HP; Q-Pharm Pty Ltd, QIMR Berghofer Medical Research Institute, And Mater Hospital and Mater Research, Queensland, Australia.
  • Byrnes-Blake K; IQ Pathology, Brisbane, Queensland, Australia.
  • Parrish-Novak J; The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
  • Ishak L; Northwest PK Solutions, LLC, Sultan, WA, USA.
  • Olson JM; Blaze Bioscience, Inc., Seattle, WA, USA.
  • Brandt G; Blaze Bioscience, Inc., Seattle, WA, USA.
  • Griffin P; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Spelman L; Brandt Biotech, LLC, Issaquah, WA, USA.
  • Prow TW; Q-Pharm Pty Ltd, QIMR Berghofer Medical Research Institute, And Mater Hospital and Mater Research, Queensland, Australia.
Contemp Clin Trials Commun ; 23: 100830, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34401600

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Australia